Dr. Ammar Qoubaitary, MD (he/him) is an Endocrinologist in San ramon, CA with over 16 years of experience. What is your opinion of Dr. Ammar Qoubaitary, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ammar Qoubaitary, MD has received over $559,396 which includes payments from the following companies:
$193,008.02 from Janssen Pharmaceuticals, Inc
$178,130.89 from Novo Nordisk Inc
$64,848.08 from AstraZeneca Pharmaceuticals LP
$51,651.36 from Boehringer Ingelheim Pharmaceuticals, Inc.
$21,885.90 from Amarin Pharma Inc.
$18,285.73 from LILLY USA, LLC
$8,418.41 from Endo Pharmaceuticals Inc.
$7,549.22 from sanofi-aventis U.S. LLC
$2,100.13 from Amgen Inc.
$1,674.99 from IBSA Pharma Inc.
$934.40 from Tandem Diabetes Care, Inc.
$931.32 from Kowa Pharmaceuticals America, Inc.
$847.61 from Radius Health, Inc.
$833.19 from Dexcom, Inc.
$741.75 from INSULET CORPORATION
$714.79 from Merck Sharp & Dohme Corporation
$700.37 from AbbVie, Inc.
$601.79 from Corcept Therapeutics
$578.66 from Takeda Pharmaceuticals U.S.A., Inc.
$560.14 from Abbott Laboratories
Payments received by Dr. Ammar Qoubaitary, MD were from the following categories:
$452,230.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!